Factor VIII concentrates are a type of medication used in the management of hemophilia A, a genetic disorder that affects blood clotting. These concentrates are made from plasma or recombinant DNA technology and are essential for patients with Factor VIII deficiency. The concentrates help in controlling and preventing bleeding episodes by replacing the deficient or missing clotting factor.